EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tau Oligomers in Alzheimer’s Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers

Sharif Arar, Md Anzarul Haque, Anas Kayed, Sheeza Khan, Nemil Bhatt, Yingxin Zhao iD, Rakez Kayed iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Sharif Arar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, University of Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau is bound to microtubules and plays a key role in their assembly and spatial organization. Under pathological conditions, tau detaches from the microtubules and develops a propensity to self-aggregate into soluble tau oligomers (TauO), paired helical filaments, and neurofibrillary tangles. Recent studies have revealed that TauO is the toxic species responsible for seeding, propagation, and development of tauopathies. Strategies that can modulate the process of TauO formation can help reduce the toxicity of TauO and stop the progression of the disease. Osmolytes are naturally occurring small-molecular-weight organic compounds, which crucially assist in the proper protein folding and thus impact the stability and solubility of proteins. Therefore, osmolytes can serve as good candidates for modulating TauO. Osmolytes cross the blood-brain barrier and act as chaperons to prevent the proteins from misfolding and aggregation. Here, we investigated the effect of different brain osmolytes against the amplified brain-derived tau oligomer (aBDTO). Our investigations have revealed that the brain osmolytes modulate the aBDTO differentially. The osmolytes sorbitol and glycerophosphocholine (GPC) displayed the potential to reduce the formation and accumulation of large aggregates by disaggregating the precursor tau oligomers into smaller assemblies with varying conformations. This may result from these osmolytes modulating the conformation of aggregated tau, which could lead to reduction in its seeding potential. However, trimethyl amine oxide (TMAO) has been found to prevent and clear out the formation of aBDTO significantly. Citrulline is less effective than TMAO and possibly affects more dimeric species. These osmolytes can become an indispensable tool for the management of Alzheimer's disease and part of hybrid therapeutic mechanisms, in addition to providing better understanding of tau oligomerization and seeding ability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseBrainHumansSorbitolAnimalsGlycerylphosphorylcholine

Stichwörter der Autor:innen

Alzheimer’s diseaseaBDTOcircular dichroismosmolytesproteinase K digestion, mass spectrometry

Substanzen

tau ProteinsSorbitolGlycerylphosphorylcholine

Autor:innen und Institutionen

  • Department of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan.
  • Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555, United States.
  • Departments of Neurology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
  • Faculty of Medicine and Health Sciences Graduate Studies, An-Najah National University, West Bank, Nablus 450, Palestine.
  • Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555, United States.
  • Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States.

ORCID-Profile: Yingxin Zhao, Rakez Kayed

Förderung

  • NIA NIH HHS
  • Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch
  • University of Jordan
  • National Institute on Aging

Zitieren

APA

Arar, S., Haque, M. A., Kayed, A., Khan, S., Bhatt, N., Zhao, Y., & Kayed, R. (2025). Tau Oligomers in Alzheimer’s Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00122

Vancouver

Arar S, Haque MA, Kayed A, Khan S, Bhatt N, Zhao Y, et al. Tau Oligomers in Alzheimer’s Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00122

BibTeX
@article{Arar2025,
  author = {Arar, Sharif and Haque, Md Anzarul and Kayed, Anas and Khan, Sheeza and Bhatt, Nemil and Zhao, Yingxin and Kayed, Rakez},
  title = {Tau Oligomers in Alzheimer’s Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00122}
}
Kostenlos starten →